News & Press Releases
Filter by:
Dole Buyers Get Mixed Win In 9th Circ. Natural Label Ruling
October 3, 2016
Dan Herling, a Litigation Member, was quoted in this Law360 article on the mixed results derived from the Ninth Circuit’s decision in favor of the consumers bringing a major false advertising complaint against Dole for falsely labeling their frozen berry products as “all-natural.”
High Court Stays Out Of College Athlete Pay Debate, For Now
October 3, 2016
Member Tyrone Thomas is quoted in this Law360 article discussing the U.S. Supreme Court’s decision denying from the NCAA and a group of former college athletes to review the existing amateurism model prohibiting college players from receiving compensation beyond scholarship packages.
Mintz Serves as Co-Bond Counsel to Brooklyn Arena Local Development Corporation in Bond Refinancing
October 03, 2016
Mintz served as co-bond counsel to the Brooklyn Arena Local Development Corporation in the refinancing of certain bonds issued for the construction of the Barclays Center in Brooklyn, NY.
Monopsony Issues in the Post-ACA World: How the Affordable Care Act May Impact Monopsony Analyses in the Review of Health Insurance Mergers
October 1, 2016
Xavier Hardy, an Associate in Mintz's Health Law practice, authored this American Bar Association Antitrust Health Care Chronicle article on what impact the Affordable Care Act may have on monopsony analyses in health insurance mergers reviews.
FTC wins appeal to halt Penn State Hershey/PinnacleHealth merger
September 28, 2016
Bruce Sokler, the Chair of Mintz’s Antitrust Practice, is quoted in a Modern Healthcare article discussing the Federal Trade Commission’s win in its appeal to stall the Penn State Hershey merger with PinnacleHealth.
Senators Ask DOJ to Investigate EpiPen-Maker Mylan
September 28, 2016
Ellyn Sternfield, a Mintz Special Counsel, is quoted in this Bloomberg BNA Health Care Daily Report article on the Department of Justice's request to look into how Mylan classified EpiPens – as generic drugs – for purposes of the Medicaid drug rebate program in 2007.
Press Contact